Sleep apnea device maker Itamar Medical said it’s debuting a new, value-based business model aimed at cardiologists, offering to help providers coordinate all stages in the diagnosis and treatment of obstructive sleep apnea and cardiovascular disease.
The Israeli company, which has offices in Franklin, Mass., said its "Total Sleep Solution" includes a national network of independent diagnostic testing facilities, durable medical equipment service providers and sleep physicians. It also includes CloudPAT, a cloud-based IT platform linking Itamar’s WatchPAT home monitor with providers.
"This approach allows us to offer more inclusive and convenient services to both patients and their physicians," CEO Gilad Glick said in prepared remarks.
The offering is something that addresses "a significant unmet need in the cardiology space, while contributing to improve the clinical outcomes of cardiovascular procedures," Glick added.
In early 2014, Itamar sealed 2 distribution deals in the U.S. and Japan for WatchPAT with Medtronic (NYSE:MDT) and Philips Healthcare (NYSE:PHG).